Twist Bioscience And Element Biosciences Announced Expanded Collaboration To Enable Element's Aviti Systems And Trinity Flowcells With Additional Twist Library Preparation And Target Enrichment Workflows.

-3.70%

Twist Bioscience

TWST

30.93

-3.70%

Offer end-to-end workflow from library prep through sequencing

Twist to be sole provider of new Trinity™ library prep and target enrichment kits for Element AVITI™ sequencer

Joint commercial activities to expand customer access to new NGS tools

Twist Bioscience Corporation (NASDAQ:TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced an expanded collaboration to enable Element's AVITI systems and Trinity flowcells with additional Twist library preparation and target enrichment workflows.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.